FIELD: medicine, biopharmacology, immunology.
SUBSTANCE: invention relates to development of agent possessing immunoregulatory property, in particular, ability to induce suppressive activity of mononuclear cells and secretion of cytokines by these cells. Proposed agent comprises trophoblastic β-1-glycoprotein and immunoglobulin (Ig) of G, A or M class. According to the second invention the agent comprising trophoblastic β-1-glycoprotein and Ig is used in treatment of autoimmune diseases and this agent is administrated by parenteral route. Invention provides the accelerated clinical effect in the autoimmune disease exacerbation stage.
EFFECT: valuable medicinal properties of agent.
9 cl, 30 tbl, 38 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR TREATING AUTOIMMUNE DISEASES | 2013 |
|
RU2528337C1 |
| PEPTIDE COMPOSITION POSSESSING IMMUNOREGULATORY PROPERTY | 2004 |
|
RU2266297C1 |
| PEPTIDE COMPOSITION ELICITING IMMUNITY REGULATING PROPERTY | 2003 |
|
RU2244719C1 |
| PEPTIDE WITH IMMUNOREGULATING PROPERTY AND COMPOSITION BASED ON THEREOF | 2002 |
|
RU2210382C1 |
| AGENT FOR TREATMENT OF AUTOIMMUNE DISEASES WITH SUPPRESSOR IMMUNODEFICIENCY AND A METHOD OF AUTOIMMUNE DISEASES TREATMENT | 1994 |
|
RU2056852C1 |
| DRUG PREPARATION POSSESSING IMMUNOREGULATORY PROPERTY FOR TREATING IMMUNE DISEASES | 2012 |
|
RU2504401C2 |
| METHOD OF HUMAN REGULATORY CD4CD25FOXP3T-CELL ENRICHMENT ex vivo | 2010 |
|
RU2437933C1 |
| METHOD OF OBTAINING POPULATION OF HUMAN CD4+CD25+Foxp3+ T-LYMPHOCYTES ex vivo, DISEASE TREATMENT METHOD | 2008 |
|
RU2391401C2 |
| IMMUNOSTIMULATING AGENT | 1998 |
|
RU2145500C1 |
| COMPOUND STIMULATING DURING EXPERIMENT SYNTHESIS OF IMMUNOGLOBULINS | 1995 |
|
RU2108096C1 |
